These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38612381)

  • 1. Design of Protease-Responsive Antifungal Liposomal Formulation Decorated with a Lipid-Modified Chitin-Binding Domain.
    Saputra H; Safaat M; Santoso P; Wakabayashi R; Goto M; Taira T; Kamiya N
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612381
    [No Abstract]   [Full Text] [Related]  

  • 2. Liposomal Amphotericin B Formulation Displaying Lipid-Modified Chitin-Binding Domains with Enhanced Antifungal Activity.
    Taniguchi H; Ishimime Y; Minamihata K; Santoso P; Komada T; Saputra H; Uchida K; Goto M; Taira T; Kamiya N
    Mol Pharm; 2022 Nov; 19(11):3906-3914. PubMed ID: 36066555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of amphotericin B-loaded hybrid liposomes and the integration of chitin-binding proteins for enhanced antifungal activity.
    Santoso P; Komada T; Ishimine Y; Taniguchi H; Minamihata K; Goto M; Taira T; Kamiya N
    J Biosci Bioeng; 2022 Sep; 134(3):259-263. PubMed ID: 35781189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of the Antifungal Activity of Chitinase by Palmitoylation and the Synergy of Palmitoylated Chitinase with Amphotericin B.
    Santoso P; Minamihata K; Ishimine Y; Taniguchi H; Komada T; Sato R; Goto M; Takashima T; Taira T; Kamiya N
    ACS Infect Dis; 2022 May; 8(5):1051-1061. PubMed ID: 35471825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of liposomal amphotericin B with extracellular and intracellular Candida albicans.
    van Etten EW; Chander HR; Snijders SV; Bakker-Woudenberg IA
    J Antimicrob Chemother; 1995 Dec; 36(6):961-74. PubMed ID: 8821595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS), with commercial lipid-based formulations.
    Fukui H; Koike T; Nakagawa T; Saheki A; Sonoke S; Tomii Y; Seki J
    Int J Pharm; 2003 Nov; 267(1-2):101-12. PubMed ID: 14602388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical method development and comparability study for AmBisome® and generic Amphotericin B liposomal products.
    Liu Y; Mei Z; Mei L; Tang J; Yuan W; Srinivasan S; Ackermann R; Schwendeman AS
    Eur J Pharm Biopharm; 2020 Dec; 157():241-249. PubMed ID: 32980448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Viscoelastic Properties of the Fungal Cell Wall Allow Traffic of AmBisome as Intact Liposome Vesicles.
    Walker L; Sood P; Lenardon MD; Milne G; Olson J; Jensen G; Wolf J; Casadevall A; Adler-Moore J; Gow NAR
    mBio; 2018 Feb; 9(1):. PubMed ID: 29437927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
    Moen MD; Lyseng-Williamson KA; Scott LJ
    Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of antifungal pharmacodynamic characteristics of AmBisome against Candida albicans.
    Takemoto K; Yamamoto Y; Ueda Y
    Microbiol Immunol; 2006; 50(8):579-86. PubMed ID: 16924142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of liposomal amphotericin B with prolonged circulation in blood versus those of AmBisome and fungizone against intracellular Candida albicans in murine peritoneal macrophages.
    van Etten EW; van Vianen W; Hak J; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2437-9. PubMed ID: 9736579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fungal fatal attraction: a mechanistic review on targeting liposomal amphotericin B (AmBisome
    Soo Hoo L
    J Liposome Res; 2017 Sep; 27(3):180-185. PubMed ID: 28805117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AmBisome targeting to fungal infections.
    Adler-Moore J
    Bone Marrow Transplant; 1994; 14 Suppl 5():S3-7. PubMed ID: 7703928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AmBisome and Amphotericin B inhibit the initial adherence of Candida albicans to human epithelial cell lines, but do not cause yeast detachment.
    Dorocka-Bobkowska B; Düzgüneş N; Konopka K
    Med Sci Monit; 2009 Sep; 15(9):BR262-9. PubMed ID: 19721394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temperature-dependent transfer of amphotericin B from liposomal membrane of AmBisome to fungal cell membrane.
    Shimizu K; Osada M; Takemoto K; Yamamoto Y; Asai T; Oku N
    J Control Release; 2010 Jan; 141(2):208-15. PubMed ID: 19815038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery.
    Lakhani P; Patil A; Wu KW; Sweeney C; Tripathi S; Avula B; Taskar P; Khan S; Majumdar S
    Int J Pharm; 2019 Dec; 572():118771. PubMed ID: 31669555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new type of plant chitinase containing LysM domains from a fern (Pteris ryukyuensis): roles of LysM domains in chitin binding and antifungal activity.
    Onaga S; Taira T
    Glycobiology; 2008 May; 18(5):414-23. PubMed ID: 18310304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience.
    Adler-Moore J; Proffitt RT
    J Antimicrob Chemother; 2002 Feb; 49 Suppl 1():21-30. PubMed ID: 11801577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dectin-1-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy.
    Ambati S; Ferarro AR; Kang SE; Lin J; Lin X; Momany M; Lewis ZA; Meagher RB
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30760610
    [No Abstract]   [Full Text] [Related]  

  • 20. Amphotericin B liposomes with prolonged circulation in blood: in vitro antifungal activity, toxicity, and efficacy in systemic candidiasis in leukopenic mice.
    van Etten EW; ten Kate MT; Stearne LE; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 1995 Sep; 39(9):1954-8. PubMed ID: 8540697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.